| Biological process | FDR | Molecular function | FDR |
---|---|---|---|---|
IC/N | ||||
 Increased | Negative regulation of plasminogen activation | 0.0409 | Protease binding | 0.0064 |
Negative regulation of metallopeptidase activity | 0.049 | Endopeptidase inhibitor activity | 0.0182 | |
Extracellular matrix disassembly | 4.33E−06 | Enzyme inhibitor activity | 0.0483 | |
Collagen catabolic process | 0.0033 | Signaling receptor binding | 7.85E−05 | |
Regulation of cellular senescence | 0.0495 | Binding | 0.0182 | |
   Decreased | Hydroxylysine biosynthetic process | 0.0491 | Procollagen-lysine 5-dioxygenase activity | 0.0042 |
Isocitrate metabolic process | 0.0092 | Procollagen-proline dioxygenase activity | 0.0164 | |
Valine metabolic process | 0.0092 | Peptide disulfide oxidoreductase activity | 0.0042 | |
Peptidyl-lysine hydroxylation | 0.016 | Racemase and epimerase activity, acting on carbohydrates and derivatives | 0.0404 | |
Positive regulation of rna polymerase ii transcription preinitiation complex assembly | 0.0252 | L-ascorbic acid binding | 0.0011 | |
ICD/N | ||||
 Decreased | Telomerase holoenzyme complex assembly | 0.0074 | Procollagen-lysine 5-dioxygenase activity | 0.0075 |
Isocitrate metabolic process | 0.00088 | Proteasome-activating atpase activity | 0.0075 | |
Positive regulation of rna polymerase ii transcription preinitiation complex assembly | 0.00022 | Isocitrate dehydrogenase activity | 0.0168 | |
Valine metabolic process | 0.0153 | Procollagen-proline dioxygenase activity | 0.0313 | |
Positive regulation of establishment of protein localization to telomere | 0.0032 | Peptide disulfide oxidoreductase activity | 0.001 |